title: [The immediate results of the use of isometronidazole in the combination therapy of patients with lung cancer].
abstract: The paper is devoted to assessment of isometronidazole tolerance, used as a radiosensitizer for preoperative irradiation of lung cancer patients, and to characterization of morphological postradiation changes in tissues of carcinomas removed at operation. Isometronidazole was shown to cause no severe side-effects in patients, improving considerably radiation injury of the tumor parenchyma.
authors.forename: V V
authors.initials: VV
authors.lastname: Zharkov
authors.forename: K Kh
authors.initials: KKh
authors.lastname: Merkle
authors.forename: M
authors.initials: M
authors.lastname: Gentshel
authors.forename: A V
authors.initials: AV
authors.lastname: Furmanchuk
authors.forename: V P
authors.initials: VP
authors.lastname: Kurchin
authors.forename: Iu E
authors.initials: IuE
authors.lastname: Demidchik
authors.forename: P I
authors.initials: PI
authors.lastname: Moiseev
mesh_terms: D000328:Adult; D003131:Combined Modality Therapy; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy / Q000532:radiotherapy* / Q000601:surgery; D008297:Male; D008795:Metronidazole / Q000031:analogs & derivatives* / Q000627:therapeutic use; D008875:Middle Aged; D011838:Radiation-Sensitizing Agents / Q000627:therapeutic use*
chemical_list: D011838:Radiation-Sensitizing Agents; D008795:Metronidazole; C031624:isometronidazole
vernacular_title: Neposredstvennye rezul'taty primeneniia izometronidazola pri kombinirovannom lechenii bol'nykh rakom legkogo.